Deaths result from failure to use conventional meds over CAM Clinical study 13 January 2013 Pages: 1 - 1
Off-label Vistide use associated with serious adverse events Correspondence 13 January 2013 Pages: 2 - 2
American Reagent is recalling two of its injectable products due to visible particles Media release 13 January 2013 Pages: 2 - 2
Novartis have issued a ‘Dear Healthcare Professional’ letter announcing the association of daptomycin [Cubicin] with pulmonary eosinophilia Correspondence 13 January 2013 Pages: 3 - 3
Safety concerns related to thromboembolism have halted enrolment in a trial of necitumumab for lung cancer Media release 13 January 2013 Pages: 3 - 3
Reports of cough and cold medicine (CCM) adverse reactions, in children < 2 years old, have substantially reduced since the marketing withdrawal Clinical study 13 January 2013 Pages: 4 - 4
Safety of 2009/2010 H1N1 vax no cause for concern in China Clinical study 13 January 2013 Pages: 4 - 4
Ciclosporin/dexamethasone/mycophenolate mofetil/prednisolone acetate Case report 13 January 2013 Pages: 12 - 13
